特尼特醫療保健公司
US ˙ NYSE ˙ US88033G4073

SecurityTHC / Tenet Healthcare Corporation
InsiderLynch Christopher S.
This page shows the track record and history of Lynch Christopher S. insider trades in Tenet Healthcare Corporation. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Lynch Christopher S. in THC / Tenet Healthcare Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

THC / Tenet Healthcare Corporation Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Lynch Christopher S. in THC / Tenet Healthcare Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-08-28 8 183.4400 8 183.4400 1,468 280 161.3700 -176 -12.00
2025-08-19 3,952 176.3900 3,952 176.3900 697,093
2024-05-30 10,861 133.8300 10,861 133.8300 1,453,528
2024-02-15 7,978 89.6000 7,978 89.6000 714,829

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

THC / Tenet Healthcare Corporation Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2026-05-26 2026-05-22 4 Lynch Christopher S. THC Common Stock M - Exercise D 1,333 13,405
2025-08-29 2025-08-28 4 Lynch Christopher S. THC Common Stock S - Sale D 183.4400 -8 -1 12,350
2025-08-21 2025-08-19 4 Lynch Christopher S. THC Common Stock S - Sale D 176.3900 -3,952 -697 12,358
2025-05-27 2025-05-23 4 Lynch Christopher S. THC Common Stock M - Exercise D 1,551 16,310
2024-06-03 2024-05-30 4 Lynch Christopher S. THC Common Stock S - Sale D 133.8300 -10,861 -1,454 14,759
2024-02-16 2024-02-15 4 Lynch Christopher S. THC Common Stock S - Sale D 89.6000 -7,978 -715 25,620
2023-06-23 2023-05-26 4/A Lynch Christopher S. THC Common Stock A - Award D 3,682 33,598
2023-05-30 2023-05-26 4 Lynch Christopher S. THC Common Stock A - Award D 2,846 32,762
2022-05-11 2022-05-09 4 Lynch Christopher S. THC Common Stock A - Award D 3,836 29,916
2021-05-11 2021-05-07 4 Lynch Christopher S. THC Common Stock A - Award D 3,960 26,080
2020-06-02 2020-05-29 4 Lynch Christopher S. THC Common Stock A - Award D 11,139 22,120
2019-09-04 2019-08-30 4 Lynch Christopher S. THC Common Stock A - Award D 10,981 10,981
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)